[1]
Zhan, B. et al. 2026. Adverse Reactions and Management Principles of JAK Inhibitors in Rheumatoid Arthritis. Journal of Contemporary Medical Practice. 8, 8 (Aug. 2026), 32–37. DOI:https://doi.org/10.66069/ojspub.27450809.